|
Originally published In Press as doi:10.1074/jbc.M110406200 on March 6, 2002
J. Biol. Chem., Vol. 277, Issue 21, 18421-18430, May 24, 2002
Identification of the Heparan Sulfate Binding Sites in the
Cellular Prion Protein*
Richard G.
Warner ,
Christoph
Hundt§,
Stefan
Weiss§¶, and
Jeremy E.
Turnbull
From the Molecular Cell Biology Laboratories, School
of Biosciences, University of Birmingham, Edgbaston, Birmingham,
England B15 2TT, United Kingdom and the § Laboratorium
für Molekulare Biologie-Genzentrum-Institut für Biochemie,
der LMU, Feodor-Lynen-Strasse 25, Munich D-81377, Germany
Data from cell culture and animal models of prion
disease support the separate involvement of both heparan sulfate
proteoglycans and copper (II) ions in prion (PrP) metabolism. Though
direct interactions between prion protein and heparin have been
recorded, little is known of the structural features implicit in this
interaction or of the involvement of copper (II) ions. Using biosensor
and enzyme-linked immunosorbent assay methodology we report direct heparin and heparan sulfate-binding activity in recombinant cellular prion protein (PrPc). We also demonstrate that the
interaction of recombinant PrPc with heparin is weakened in
the presence of Cu(II) ions and is particularly sensitive to
competition with dextran sulfate. Competitive inhibition experiments
with chemically modified heparins also indicate that
2-O-sulfate groups (but not 6-O-sulfate groups) are essential for heparin recognition. We have also identified three
regions of the prion protein capable of independent binding to heparin
and heparan sulfate: residues 23-52, 53-93, and 110-128. Interestingly, the interaction of an octapeptide-spanning peptide motif
amino acids 53-93 with heparin is enhanced by Cu(II) ions. Significantly, a peptide of this sequence is able to inhibit the binding of full-length prion molecule to heparin, suggesting a direct
role in heparin recognition within the intact protein. The collective
data suggest a complex interaction between prion protein and
heparin/heparan sulfate and has implications for the cellular and
pathological functions of prion proteins.
*
This work was supported in part by Grants BIOMED PL976054
and QLRT-2000-02085 from the European Union.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by Grants KI-01-9760 and 01-KO-0106
(Bundeministerium für Bildung und Forschung) and LMU 3 and
4 (Bavarian Prion Research Foundation).
Recipient of a Medical Research Council (UK) Senior Research
Fellowship. To whom correspondence should be addressed: Tel.: 44-0-121-414-7527; Fax: 44-0-870-121-0564; E-mail:
j.e.turnbull@bham.ac.uk.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Guillerme-Bosselut, L. Forestier, C. Jayat-Vignoles, J.-L. Vilotte, I. Popa, J. Portoukalian, A. Le Dur, H. Laude, R. Julien, and P.-F. Gallet
Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse
Glycobiology,
August 1, 2009;
19(8):
879 - 889.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Haigh, S. C. Drew, M. P. Boland, C. L. Masters, K. J. Barnham, V. A. Lawson, and S. J. Collins
Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection response
J. Cell Sci.,
May 15, 2009;
122(10):
1518 - 1528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Deleault, N. R. Deleault, B. T. Harris, J. R. Rees, and S. Supattapone
The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie
J. Gen. Virol.,
October 1, 2008;
89(10):
2642 - 2650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani
Physiology of the Prion Protein
Physiol Rev,
April 1, 2008;
88(2):
673 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Parkyn, E. G. M. Vermeulen, R. C. Mootoosamy, C. Sunyach, C. Jacobsen, C. Oxvig, S. Moestrup, Q. Liu, G. Bu, A. Jen, et al.
LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein
J. Cell Sci.,
March 15, 2008;
121(6):
773 - 783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Lee, L. D. Raymond, B. Schoen, G. J. Raymond, L. Kett, R. A. Moore, L. M. Johnson, L. Taubner, J. O. Speare, H. A. Onwubiko, et al.
Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein
J. Biol. Chem.,
December 14, 2007;
282(50):
36525 - 36533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Geoghegan, P. A. Valdes, N. R. Orem, N. R. Deleault, R. A. Williamson, B. T. Harris, and S. Supattapone
Selective Incorporation of Polyanionic Molecules into Hamster Prions
J. Biol. Chem.,
December 14, 2007;
282(50):
36341 - 36353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. T. Parkin, N. T. Watt, I. Hussain, E. A. Eckman, C. B. Eckman, J. C. Manson, H. N. Baybutt, A. J. Turner, and N. M. Hooper
Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein
PNAS,
June 26, 2007;
104(26):
11062 - 11067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yin, N. Pham, S. Yu, C. Li, P. Wong, B. Chang, S.-C. Kang, E. Biasini, P. Tien, D. A. Harris, et al.
Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans
PNAS,
May 1, 2007;
104(18):
7546 - 7551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Larramendy-Gozalo, A. Barret, E. Daudigeos, E. Mathieu, L. Antonangeli, C. Riffet, E. Petit, D. Papy-Garcia, D. Barritault, P. Brown, et al.
Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases
J. Gen. Virol.,
March 1, 2007;
88(3):
1062 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yin, S. Yu, C. Li, P. Wong, B. Chang, F. Xiao, S.-C. Kang, H. Yan, G. Xiao, J. Grassi, et al.
Prion Proteins with Insertion Mutations Have Altered N-terminal Conformation and Increased Ligand Binding Activity and Are More Susceptible to Oxidative Attack
J. Biol. Chem.,
April 21, 2006;
281(16):
10698 - 10705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sekiya, K. Noda, F. Nishikawa, T. Yokoyama, P. K.R. Kumar, and S. Nishikawa
Characterization and Application of a Novel RNA Aptamer against the Mouse Prion Protein.
J. Biochem.,
March 1, 2006;
139(3):
383 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rezaie, C. C. Pontikis, L. Hudson, N. J. Cairns, and P. L. Lantos
Expression of Cellular Prion Protein in the Frontal and Occipital Lobe in Alzheimer's Disease, Diffuse Lewy Body Disease, and in Normal Brain: An Immunohistochemical Study
J. Histochem. Cytochem.,
August 1, 2005;
53(8):
929 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Deleault, J. C. Geoghegan, K. Nishina, R. Kascsak, R. A. Williamson, and S. Supattapone
Protease-resistant Prion Protein Amplification Reconstituted with Partially Purified Substrates and Synthetic Polyanions
J. Biol. Chem.,
July 22, 2005;
280(29):
26873 - 26879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hijazi, Z. Kariv-Inbal, M. Gasset, and R. Gabizon
PrPSc Incorporation to Cells Requires Endogenous Glycosaminoglycan Expression
J. Biol. Chem.,
April 29, 2005;
280(17):
17057 - 17061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Horonchik, S. Tzaban, O. Ben-Zaken, Y. Yedidia, A. Rouvinski, D. Papy-Garcia, D. Barritault, I. Vlodavsky, and A. Taraboulos
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
J. Biol. Chem.,
April 29, 2005;
280(17):
17062 - 17067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. West, C. G. Rees, L. Duchesne, S. J. Patey, C. J. Terry, J. E. Turnbull, M. Delehedde, C. W. Heegaard, F. Allain, C. Vanpouille, et al.
Interactions of Multiple Heparin Binding Growth Factors with Neuropilin-1 and Potentiation of the Activity of Fibroblast Growth Factor-2
J. Biol. Chem.,
April 8, 2005;
280(14):
13457 - 13464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Barret, L. Forestier, J.-P. Deslys, R. Julien, and P. F. Gallet
Glycosylation-related Gene Expression in Prion Diseases: PrPSc ACCUMULATION IN SCRAPIE INFECTED GT1 CELLS DEPENDS ON {beta}-1,4-LINKED GalNAc-4-SO4 HYPOSULFATION
J. Biol. Chem.,
March 18, 2005;
280(11):
10516 - 10523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nishina, S. Jenks, and S. Supattapone
Ionic Strength and Transition Metals Control PrPSc Protease Resistance and Conversion-inducing Activity
J. Biol. Chem.,
September 24, 2004;
279(39):
40788 - 40794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Jones, B. Yazzie, and C. R. Middaugh
Polyanions and the Proteome
Mol. Cell. Proteomics,
August 1, 2004;
3(8):
746 - 769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Scholefield, E. A. Yates, G. Wayne, A. Amour, W. McDowell, and J. E. Turnbull
Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's {beta}-secretase
J. Cell Biol.,
October 13, 2003;
163(1):
97 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rhie, L. Kirby, N. Sayer, R. Wellesley, P. Disterer, I. Sylvester, A. Gill, J. Hope, W. James, and A. Tahiri-Alaoui
Characterization of 2'-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion
J. Biol. Chem.,
October 10, 2003;
278(41):
39697 - 39705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Ben-Zaken, S. Tzaban, Y. Tal, L. Horonchik, J. D. Esko, I. Vlodavsky, and A. Taraboulos
Cellular Heparan Sulfate Participates in the Metabolism of Prions
J. Biol. Chem.,
October 10, 2003;
278(41):
40041 - 40049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mani, F. Cheng, B. Havsmark, M. Jonsson, M. Belting, and L.-A. Fransson
Prion, Amyloid {beta}-derived Cu(II) Ions, or Free Zn(II) Ions Support S-Nitroso-dependent Autocleavage of Glypican-1 Heparan Sulfate
J. Biol. Chem.,
October 3, 2003;
278(40):
38956 - 38965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lane, C. J. Stanley, S. Dealler, and S. M. Wilson
Polymeric Ligands with Specificity for Aggregated Prion Proteins
Clin. Chem.,
October 1, 2003;
49(10):
1774 - 1775.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Adjou, S. Simoneau, N. Sales, F. Lamoury, D. Dormont, D. Papy-Garcia, D. Barritault, J.-P. Deslys, and C. I. Lasmezas
A novel generation of heparan sulfate mimetics for the treatment of prion diseases
J. Gen. Virol.,
September 1, 2003;
84(9):
2595 - 2603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Dormont
Approaches to prophylaxis and therapy: An investigation into prion disease diversity
Br. Med. Bull.,
June 1, 2003;
66(1):
281 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Baron and B. Caughey
Effect of Glycosylphosphatidylinositol Anchor-dependent and -independent Prion Protein Association with Model Raft Membranes on Conversion to the Protease-resistant Isoform
J. Biol. Chem.,
April 18, 2003;
278(17):
14883 - 14892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Riley, C. Leucht, S. Gauczynski, C. Hundt, M. Brecelj, G. Dodson, and S. Weiss
High-level expression and characterization of a glycosylated covalently linked dimer of the prion protein
Protein Eng. Des. Sel.,
June 1, 2002;
15(6):
529 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gauczynski, S. Krasemann, W. Bodemer, and S. Weiss
Recombinant human prion protein mutants huPrP D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase K resistance
J. Cell Sci.,
January 11, 2002;
115(21):
4025 - 4036.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|